Dr. Robert Orlowski – One of Myeloma Survival’s GREAT EIGHT Discusses How Clinical Trials Have Changed  Myeloma Treatment at MD Anderson

Dr. Orlowski was featured on the Cure Panel broadcast of March 28th.  He discussed the role of Clinical Trials in the development and improvement of treatments for multiple myeloma at MD Anderson. You can listen to a rebroadcast of the program if your CLICK HERE.  You might want to know more about Dr. Orlowski, and I have included a quick bio for Dr. Orlowski at the end of this post.  It is my belief, a select few myeloma specialists stand above the rest.  I believe Dr. Orlowski is one of them. These myeloma specialists are innovators, leaders, teachers, patient centric, dedicated, extremely skilled in myeloma treatment, driven, have well above average life expectancies and survival rates, and are just exceptional caring and kind individuals. 


 It is not  that all of the myeloma specialists do not have these characteristics, but there is a cream that rises to the surface. 
So who are the top picks of www.myelomasurvival.com.  The GREAT EIGHT  In alphabetical order, our SUPER myeloma specialists.

Dr. Barlogie – UAMS, Little Rock AR
Dr. Berenson – IMBCR – Los Angeles,CA  
Dr. Hari – Medical College of Wisconsin, Milwaukee, WI
Dr. San Miguel – University Hospital, Salamanca, Spain
Dr. Orlowski – M.D Anderson, Houston, TX
Dr. Palumbo – University of Torino, Italy
Dr. Rajkumar – Mayo, Rochester, MN
Dr. Richardson – Dana Farber Cancer Institute, Boston, MA  

Everyone will have an opinion, however, I think few can deny the quality of myeloma specialists represented on this list.  Many people will not be able to chose one of these doctors for their doctor for a number of reasons, however there is a good chance you can get a second opinion from one of them which could be the template for your local myeloma specialist to implement.   What is remarkable about this list is they each have their own treatment philosophy which goes from “Less is Best” to “More is Cure”, and due to their experience and skill have provided exceptional outcomes for their patient’s.

Short Bio

Robert Z. Orlowski, MD, PhD, is Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. He is board-certified in internal medicine and medical oncology. Dr. Orlowski earned his doctoral degree in molecular biophysics and biochemistry from Yale University and his medical degree from the Yale University School of Medicine. He completed his internship and residency in Internal Medicine at Barnes Hospital at the Washington University in St. Louis School of Medicine. Dr. Orlowski has published numerous book chapters, articles, and abstracts on cancer therapy, with a focus on the molecular pathogenesis of oncologic disease processes and the mechanisms of action of chemotherapeutics.

About the Author